Related Experiment Video
Updated: Jul 11, 2026
A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
Published on: May 16, 2015
Combined Omega-3 Fatty Acid and Folic Acid Supplementation Reduces Neonatal Hypoxic-Ischemic Brain Injury via
Wendong Sun1, Tanu Ojha2, Vinod Kumar Verma2
1Department of Neurosurgery, Baoding First Central Hospital, Baoding, Hebei Province, 071000, China.
Insights
Combined omega-3 polyunsaturated fatty acids (PUFAs) and folic acid (FA) significantly protect against neonatal hypoxic-ischemic (HI) brain injury. This synergistic supplementation reduces brain damage, inflammation, and apoptosis, improving neuroprotection and functional recovery.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Neonatal hypoxic-ischemic (HI) injury causes neuronal death, a significant clinical challenge.
- Omega-3 polyunsaturated fatty acids (PUFAs) possess known antioxidative and anti-inflammatory properties.
- Folic acid (FA) has been linked to apoptosis regulation in neural stem cells and neurons.
Purpose of the Study:
- To investigate the neuroprotective efficacy of combined PUFA and FA supplementation against neonatal HI brain injury.
- To assess the impact of this combination therapy on apoptosis, inflammation, neurotransmitter balance, and electrophysiological function.
- To determine if combined PUFA and FA offers enhanced neuroprotection and functional recovery compared to individual treatments.
Main Methods:
- Evaluation of brain tissue damage, including infarct size, using histological analysis.
- Measurement of electrophysiological parameters such as orthodromic population spike (OPS) and hypoxic injury potential (HIP).
- Assay of hippocampal amino acid neurotransmitters and inflammatory/apoptotic markers in brain tissue and cell cultures.
Main Results:
- Combined PUFA-FA treatment reduced HI-induced brain infarct size by 88% and improved cognitive and motor functions.
- Electrophysiological assessments showed enhanced OPS parameters and delayed HIP onset/duration.
- The treatment suppressed pro-inflammatory cytokines, chemokines, and key apoptosis-related genes (AIF, caspase-3, PARP).
Conclusions:
- Combined PUFA and FA supplementation demonstrates synergistic neuroprotective effects against neonatal HI brain injury.
- The treatment effectively mitigates neuronal degeneration, inflammation, and apoptosis.
- This combination therapy holds promise for restoring cognitive and motor functions impaired by HI injury.
Background:
Neonatal hypoxic ischemia (HI) injury results in neuronal cell death, which remains clinically challenging to mitigate. Omega-3 polyunsaturated fatty acids (PUFAs) are known for their antioxidative and anti-inflammatory effects. Folic acid (FA) correlates with apoptosis in neural stem cells and neurons.
Objectives:
This study aimed to evaluate whether combined PUFA and FA supplementation mitigates neonatal HI brain injury by reducing apoptosis, inflammation, neurotransmitter imbalance, and electrophysiological dysfunction, thereby offering enhanced neuroprotection and functional recovery.
Methods:
Brain tissue damage, orthodromic population spike (OPS), and hypoxic injury potential (HIP) were measured. Amino acid neurotransmitter concentration in the hippocampus sections was measured. Markers of inflammation and apoptosis were assayed from HI-induced rat brains and lipopolysaccharide (LPS)-induced microglia BV-2 cells.
Results:
The HI caused severe damage to brain tissues that were potentially prevented by PUFA-FA by reducing the infarct size by 88%. The PUFA-FA treatment decreased the latency time (51 and 43 s) and increased swimming velocity (152 and 170 mm/s) on training days 3 and 5. The PUFA-FA showed an improved OPS decay time of 327 s, OPS recovery rate (62 s), and recovery amplitude (58 s). Whereas it caused an average 57% HIP incidence with a notably delayed onset (564 s) and duration (182 s). The PUFA-FA treatment also decreased the HI-induced release of amino acid neurotransmitters (Asp, Glu, and Gly) and GABA. The PUFA-FA suppressed the levels of proinflammatory cytokines and chemokines (iNOS, COX-2, TNF-α, IL-1β, and IL-6) and might mediate the inhibition of the NF-κB signaling pathway. The PUFA-FA reduced apoptosis as evidenced by lowered expression of AIF, caspase-3, and PARP genes.
Conclusions:
The PUFA and FA reduced HI-induced brain infarct size, with the combination showing greater protection compared to individual effects. Both improved cognitive performances, decreasing latency times and enhancing swimming velocity. The PUFA-FA supplementation synergistically restored memory, learning, and motor functions, highlighting strong neuroprotective effects against HI-induced neuronal degeneration and cognitive impairments.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
03:19Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
